| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 9774 | [Tyr3]Octreotate acetate |
9774.0001: 1 mg per vial 9774.0010: 10 mg per vial Please inquire for customized filling and bulk quantities. 
|
|
|
||
| Molar Mass: 1049.22 | ||
| C49H64N10O12S2 | ||
| [302794-43-0] (net peptide) | ||
| Colourless freeze-dried solid packaged in screw cap vials. | ||
| Purity: ≥ 95 % | ||
|
Certificates:
CoA; MS (identity); HPLC (purity) |
||
|
Chemical Name: Sequence: H-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr-OH, cyclic disulfide |
||
|
Synonymes: TATE; TOCA; CA index name: L-Threonine, D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-, cyclic (2→7)-disulfide |
||
|
Literature: Petrou C. et al. Synthesis and sst2 binding profiles of new (Tyr3)octreotate analogs. J.Peptide Sci. 2008, 14, 725-730. |
||
| Spyroulias G.A. et al. 3D solution structure of [Tyr3]octreotate derivatives in DMSO: Structure differentiation of peptide core due to chelate group attachment and biologically active conformation. Med. Chem. 2005, 1, 487-499. | ||
| Wang Q. et al. Pharmacological properties of hydrophilic and lipophilic derivatives of octreotate. Nucl. Med. Biol. 2004, 31, 21-30. | ||
| date of product catalogue issue: 10 May 2017 | ||